Keyvan Rezaï (Keyvan Rezai)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Venues

Journal of labelled compounds & radiopharmaceuticals

Clinical cancer research : an official journal of the American Association for Cancer Research

Annals of work exposures and health

Cancer chemotherapy and pharmacology

Institut Curie

Institut Curie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Curie

France

Deputy Head of Deaprtment :: Radio-Pharmacology

Education History

Institut Curie

France

PHD :: Radio-Pharmacology

Publications

Alexandre Acramel, Julien Fouque, Sandy Blondeel-Gomes, Samuel Huguet, Keyvan Rezaï, Olivier Madar, Laurence Escalup
Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center. Annals of work exposures and health 66 (9) (2022)
Julien Fouque, Timofei Rusu, Samuel Huguet, Emilie Da Costa Branquinho, Sandy Blondeel-Gomes, Keyvan Rezaï, Olivier Madar
Ultra-fast liquid chromatography method coupled with ultraviolet detection to quantify dimethylsulfoxide, dimethylformamide and dimethylacetamide in short half-lives radiopharmaceuticals. Journal of labelled compounds & radiopharmaceuticals 64 (11) (2021)
Baptiste Louveau, Matthieu Resche-Rigon, Thierry Lesimple, Laetitia Da Meda, Marc Pracht, Barouyr Baroudjian, Julie Delyon, Mona Amini-Adle, Caroline Dutriaux, Coralie Reger de Moura, Aurélie Sadoux, Fanélie Jouenne, Zineb Ghrieb, Paul Vilquin, Didier Bouton, Annick Tibi, Samuel Huguet, Keyvan Rezaï, Maxime Battistella, Samia Mourah, Céleste Lebbe
Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
E Baudry, S Huguet, A L Couderc, P Chaibi, F Bret, C Verny, S Weill, O Madar, S Urien, Keyvan Rezaï
Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP. Cancer chemotherapy and pharmacology 83 (4) (2019)

Keyvan Rezaï.css-eqlu8i{font-size:small;padding-left:4px;} (Keyvan Rezai)

Publication Activity (10 Years)

Top Topics

Top Venues

Keyvan Rezaï (Keyvan Rezai)